相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome database mining for the discovery of novel lantibiotics
Stephanie K. Sandiford
EXPERT OPINION ON DRUG DISCOVERY (2017)
Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation
Torbjorn Bengtsson et al.
PATHOGENS AND DISEASE (2017)
Antibiotic resistance
Marianne Frieri et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2017)
Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria
J. M. Ageitos et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance
Laura J. V. Piddock
LANCET INFECTIOUS DISEASES (2016)
Antibacterial drug discovery in the resistance era
Eric D. Brown et al.
NATURE (2016)
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options
S. M. Purrello et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2016)
Interaction of blood components with cathelicidins and their modified versions
Kai Yu et al.
BIOMATERIALS (2015)
The use of erythrocyte fragility to assess xenobiotic cytotoxicity
Maria Pagano et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
Bacteriocins and their position in the next wave of conventional antibiotics
Veronica L. Cavera et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2014)
Update on the antibiotic resistance crisis
Gian Maria Rossolini et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Epidermin and gallidermin: Staphylococcal lantibiotics
Friedrich Goetz et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Lantibiotics: Promising candidates for future applications in health care
Jasmin Dischinger et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Porphyromonas gingivalis downregulates the immune response of fibroblasts
Eleonor Palm et al.
BMC MICROBIOLOGY (2013)
Manipulation of innate immunity by a bacterial secreted peptide: Lantibiotic nisin Z is selectively immunomodulatory
Jason Kindrachuk et al.
INNATE IMMUNITY (2013)
Activity of Gallidermin on Staphylococcus aureus and Staphylococcus epidermidis Biofilms
Jongkon Saising et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria
Sibel Dosler et al.
JOURNAL OF CHEMOTHERAPY (2012)
Preserving the Lifesaving Power of Antimicrobial Agents
James M. Hughes
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids
Christoph M. Ernst et al.
MOLECULAR MICROBIOLOGY (2011)
Plantaricin A synthesized by Lactobacillus plantarum induces in vitro proliferation and migration of human keratinocytes and increases the expression of TGF-β1, FGF7, VEGF-A and IL-8 genes
Daniela Pinto et al.
PEPTIDES (2011)
Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes
Aranya Manosroi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
Matthew E. Levison et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Lantibiotics: Diverse activities and unique modes of action
Sikder M. Asaduzzaman et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2009)
Staphylococcus epidermidis - the 'accidental' pathogen
Michael Otto
NATURE REVIEWS MICROBIOLOGY (2009)
The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
Christoph M. Ernst et al.
PLOS PATHOGENS (2009)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci
Silvia Herbert et al.
PLOS PATHOGENS (2007)
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
Ajit K. Sarmah et al.
CHEMOSPHERE (2006)
Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro
S Maher et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies
RR Bonelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance
P Staubitz et al.
FEMS MICROBIOLOGY LETTERS (2004)
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics
STD Hsu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Assembly and stability of nisin-Lipid II pores
HE Hasper et al.
BIOCHEMISTRY (2004)
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes
E Breukink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The emergence and evolution of methicillin-resistant Staphylococcus aureus
K Hiramatsu et al.
TRENDS IN MICROBIOLOGY (2001)
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine
A Peschel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity
I Wiedemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens
M Mota-Meira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
